IRADIMED CORP (IRMD) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IRMD • US46266A1097

93.85 USD
-4.13 (-4.22%)
At close: Feb 4, 2026
93.85 USD
0 (0%)
After Hours: 2/4/2026, 8:28:52 PM
Fundamental Rating

7

IRMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. IRMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IRMD has a correct valuation and a medium growth rate. These ratings would make IRMD suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year IRMD was profitable.
  • IRMD had a positive operating cash flow in the past year.
  • IRMD had positive earnings in each of the past 5 years.
  • IRMD had a positive operating cash flow in each of the past 5 years.
IRMD Yearly Net Income VS EBIT VS OCF VS FCFIRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 18.47%, IRMD belongs to the top of the industry, outperforming 98.92% of the companies in the same industry.
  • IRMD has a better Return On Equity (21.54%) than 94.62% of its industry peers.
  • IRMD's Return On Invested Capital of 19.30% is amongst the best of the industry. IRMD outperforms 97.31% of its industry peers.
  • IRMD had an Average Return On Invested Capital over the past 3 years of 18.78%. This is significantly above the industry average of 8.80%.
  • The last Return On Invested Capital (19.30%) for IRMD is above the 3 year average (18.78%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.47%
ROE 21.54%
ROIC 19.3%
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
IRMD Yearly ROA, ROE, ROICIRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

  • IRMD has a better Profit Margin (26.31%) than 96.24% of its industry peers.
  • IRMD's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 30.87%, IRMD belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
  • IRMD's Operating Margin has improved in the last couple of years.
  • IRMD has a Gross Margin of 77.07%. This is amongst the best in the industry. IRMD outperforms 89.78% of its industry peers.
  • IRMD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 30.87%
PM (TTM) 26.31%
GM 77.07%
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
IRMD Yearly Profit, Operating, Gross MarginsIRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IRMD is creating value.
  • IRMD has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, IRMD has more shares outstanding
  • IRMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IRMD Yearly Shares OutstandingIRMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
IRMD Yearly Total Debt VS Total AssetsIRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • IRMD has an Altman-Z score of 46.74. This indicates that IRMD is financially healthy and has little risk of bankruptcy at the moment.
  • IRMD's Altman-Z score of 46.74 is amongst the best of the industry. IRMD outperforms 98.92% of its industry peers.
  • IRMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 46.74
ROIC/WACC1.9
WACC10.16%
IRMD Yearly LT Debt VS Equity VS FCFIRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 6.64 indicates that IRMD has no problem at all paying its short term obligations.
  • IRMD has a better Current ratio (6.64) than 84.41% of its industry peers.
  • IRMD has a Quick Ratio of 5.72. This indicates that IRMD is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 5.72, IRMD belongs to the top of the industry, outperforming 84.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 5.72
IRMD Yearly Current Assets VS Current LiabilitesIRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • IRMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.75%, which is quite good.
  • IRMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.92% yearly.
  • Looking at the last year, IRMD shows a quite strong growth in Revenue. The Revenue has grown by 12.91% in the last year.
  • The Revenue has been growing by 13.71% on average over the past years. This is quite good.
EPS 1Y (TTM)13.75%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%9.3%
Revenue 1Y (TTM)12.91%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%15.69%

3.2 Future

  • Based on estimates for the next years, IRMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.26% on average per year.
  • Based on estimates for the next years, IRMD will show a quite strong growth in Revenue. The Revenue will grow by 8.97% on average per year.
EPS Next Y15.29%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y11.69%
Revenue Next 3Y8.97%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IRMD Yearly Revenue VS EstimatesIRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
IRMD Yearly EPS VS EstimatesIRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 51.57, the valuation of IRMD can be described as expensive.
  • IRMD's Price/Earnings ratio is a bit cheaper when compared to the industry. IRMD is cheaper than 69.35% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.25. IRMD is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 43.40, the valuation of IRMD can be described as expensive.
  • Based on the Price/Forward Earnings ratio, IRMD is valued a bit cheaper than the industry average as 68.82% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 27.50. IRMD is valued rather expensively when compared to this.
Industry RankSector Rank
PE 51.57
Fwd PE 43.4
IRMD Price Earnings VS Forward Price EarningsIRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 66.67% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, IRMD is valued a bit cheaper than 70.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 85.57
EV/EBITDA 44.02
IRMD Per share dataIRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRMD does not grow enough to justify the current Price/Earnings ratio.
  • IRMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.37
PEG (5Y)3.7
EPS Next 2Y14.48%
EPS Next 3Y9.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • IRMD has a yearly dividend return of 0.69%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.21, IRMD pays a better dividend. On top of this IRMD pays more dividend than 91.40% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, IRMD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.69%

5.2 History

  • IRMD has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IRMD Yearly Dividends per shareIRMD Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • IRMD pays out 39.59% of its income as dividend. This is a sustainable payout ratio.
DP39.59%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
IRMD Yearly Income VS Free CF VS DividendIRMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
IRMD Dividend Payout.IRMD Dividend Payout, showing the Payout Ratio.IRMD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IRADIMED CORP

NASDAQ:IRMD (2/4/2026, 8:28:52 PM)

After market: 93.85 0 (0%)

93.85

-4.13 (-4.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-03
Earnings (Next)02-11
Inst Owners57.86%
Inst Owner Change-0.33%
Ins Owners36.79%
Ins Owner Change-0.63%
Market Cap1.19B
Revenue(TTM)80.51M
Net Income(TTM)21.18M
Analysts82.5
Price Target100.98 (7.6%)
Short Float %5.64%
Short Ratio5.73
Dividend
Industry RankSector Rank
Dividend Yield 0.69%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP39.59%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.85%
Min EPS beat(2)1.27%
Max EPS beat(2)10.44%
EPS beat(4)3
Avg EPS beat(4)2.54%
Min EPS beat(4)-1.96%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.28%
EPS beat(12)10
Avg EPS beat(12)6.04%
EPS beat(16)14
Avg EPS beat(16)9.77%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.01%
Max Revenue beat(2)1.41%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.41%
Revenue beat(8)3
Avg Revenue beat(8)-0.25%
Revenue beat(12)6
Avg Revenue beat(12)-0.02%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0%
PT rev (3m)32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.13%
EPS NY rev (1m)0%
EPS NY rev (3m)1.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.35%
Valuation
Industry RankSector Rank
PE 51.57
Fwd PE 43.4
P/S 14.83
P/FCF 85.57
P/OCF 47.73
P/B 12.14
P/tB 12.57
EV/EBITDA 44.02
EPS(TTM)1.82
EY1.94%
EPS(NY)2.16
Fwd EY2.3%
FCF(TTM)1.1
FCFY1.17%
OCF(TTM)1.97
OCFY2.1%
SpS6.33
BVpS7.73
TBVpS7.47
PEG (NY)3.37
PEG (5Y)3.7
Graham Number17.79
Profitability
Industry RankSector Rank
ROA 18.47%
ROE 21.54%
ROCE 24.38%
ROIC 19.3%
ROICexc 43.34%
ROICexgc 46.82%
OM 30.87%
PM (TTM) 26.31%
GM 77.07%
FCFM 17.33%
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
ROICexc(3y)57.41%
ROICexc(5y)N/A
ROICexgc(3y)63.62%
ROICexgc(5y)N/A
ROCE(3y)23.73%
ROCE(5y)N/A
ROICexgc growth 3Y-6.9%
ROICexgc growth 5Y0.27%
ROICexc growth 3Y-6.89%
ROICexc growth 5Y-0.24%
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 1128.47%
Cap/Sales 13.74%
Interest Coverage 250
Cash Conversion 96.82%
Profit Quality 65.85%
Current Ratio 6.64
Quick Ratio 5.72
Altman-Z 46.74
F-Score4
WACC10.16%
ROIC/WACC1.9
Cap/Depr(3y)801.75%
Cap/Depr(5y)501.1%
Cap/Sales(3y)9.26%
Cap/Sales(5y)6.31%
Profit Quality(3y)60.91%
Profit Quality(5y)134.72%
High Growth Momentum
Growth
EPS 1Y (TTM)13.75%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%9.3%
EPS Next Y15.29%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
EPS Next 5YN/A
Revenue 1Y (TTM)12.91%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%15.69%
Revenue Next Year13.26%
Revenue Next 2Y11.69%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
EBIT growth 1Y16.55%
EBIT growth 3Y30.78%
EBIT growth 5Y20.49%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y194.31%
FCF growth 3Y16.9%
FCF growth 5Y11.53%
OCF growth 1Y98.66%
OCF growth 3Y31.53%
OCF growth 5Y20.16%

IRADIMED CORP / IRMD FAQ

Can you provide the ChartMill fundamental rating for IRADIMED CORP?

ChartMill assigns a fundamental rating of 7 / 10 to IRMD.


Can you provide the valuation status for IRADIMED CORP?

ChartMill assigns a valuation rating of 4 / 10 to IRADIMED CORP (IRMD). This can be considered as Fairly Valued.


Can you provide the profitability details for IRADIMED CORP?

IRADIMED CORP (IRMD) has a profitability rating of 9 / 10.


What are the PE and PB ratios of IRADIMED CORP (IRMD) stock?

The Price/Earnings (PE) ratio for IRADIMED CORP (IRMD) is 51.57 and the Price/Book (PB) ratio is 12.14.


Can you provide the financial health for IRMD stock?

The financial health rating of IRADIMED CORP (IRMD) is 9 / 10.